Idenix Pharmaceuticals

Contact
idenix.com
+1617-995-9800

Idenix Pharmaceuticals, Inc.

60 Hampshire Street
02139 Cambridge
USA
+1617-995-9800
idenix.com
Contact
Profile News
Contact

About Idenix Pharmaceuticals

Idenix Pharmaceuticals, Inc., headquartered in Cambridge, MA, is a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases. Idenix's current focus is on the treatment of infections caused by hepatitis C virus (HCV) and human immunodeficiency virus (HIV).

Read more about Idenix Pharmaceuticals
Facts about Idenix Pharmaceuticals
  • Industry : Pharma

News about Idenix Pharmaceuticals

Idenix Pharmaceuticals

14-Jun-2010 | research and development

Idenix Pharmaceuticals Initiates Proof-of-Concept Study for Protease Inhibitor IDX320 in Hepatitis C Patients

Idenix Pharmaceuticals, Inc. announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis ...

Read news
Idenix Pharmaceuticals

03-Nov-2009 | research and development

Idenix Pharmaceuticals Presents Data on IDX184 for the Treatment of Hepatitis C Virus (HCV)

Idenix Pharmaceuticals, Inc. announced presentations of data on IDX184, a once-daily novel liver-targeted nucleotide prodrug of 2'-methyl guanosine (2'MeG ...

Read news
Idenix Pharmaceuticals

25-Nov-2005 | business & finance

Galapagos enters into discovery collaboration with Idenix for infectious disease programs

Galapagos NV announced that it has entered into a collaboration with Idenix Pharmaceuticals, Inc. on selected hepatitis and HIV infectious disease programs ...

Read news
Idenix Pharmaceuticals

31-May-2002 | business & finance

Novirio Pharmaceuticals Limited Becomes Idenix Pharmaceuticals , Inc.

CAMBRIDGE, Mass., May 29, 2002 - Novirio Pharmaceuticals Limited, a biopharmaceutical company engaged in the discovery and development of drugs for the ...

Read news
Show more news about Idenix Pharmaceuticals

Here you will find Idenix Pharmaceuticals, Inc.